ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 12 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - somatropin - אבקה וממס להכנת תמיסה להזרקה - somatropin 10 mg - somatropin - somatropin - short stature due to pituitary growth hormone deficiency turner's syndrome, children suffering from renal insufficiency. children : short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 250 mcg/ml - teriparatide - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, forteo increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:forteo is indicated for the treatment of men and women with osteopo

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - insulin glargine - תמיסה להזרקה - insulin glargine 100 u/ml - insulin glargine

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 100 u/ml - insulin degludec

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 200 u/ml - insulin degludec

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - treprostinil - תמיסה להזרקה\אינפוזיה - treprostinil 10 mg / 1 ml - treprostinil

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - treprostinil - תמיסה להזרקה\אינפוזיה - treprostinil 2.5 mg / 1 ml - treprostinil

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - treprostinil - תמיסה להזרקה\אינפוזיה - treprostinil 5 mg / 1 ml - treprostinil

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin detemir - תמיסה להזרקה - insulin detemir 100 u/ml - insulin detemir